About Redesign Science
Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic and inflammatory diseases.
|
|
|
11-50 employees
View all Redesign Science employees
|
|
Biotechnology
|
|
180 Varick St, New York, US
|
|
2017
|
Redesign Science Alternatives
Frequently Asked Questions about Redesign Science
David Rooklin is the CEO of Redesign Science. To contact David Rooklin email at [email protected] or [email protected].
The decision makers in Redesign Science are Sharon Blaettler, David Rooklin, Gavin Bascom, etc. Click to Find Redesign Science decision makers emails.
Redesign Science Staff Directory
Search Redesign Science Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
